SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607950. A total of 4 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,303,700 | -22.1% | 85,000 | -26.4% | 0.00% | -25.0% |
| Q2 2023 | $13,227,060 | -58.2% | 115,500 | -49.7% | 0.00% | -69.2% |
| Q1 2023 | $31,659,551 | +286.6% | 229,700 | +263.4% | 0.01% | +225.0% |
| Q4 2022 | $8,189,456 | +53.4% | 63,200 | +30.8% | 0.00% | +100.0% |
| Q3 2022 | $5,339,000 | +365.5% | 48,300 | +215.7% | 0.00% | – |
| Q2 2022 | $1,147,000 | – | 15,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 29,250 | $55,780,000 | 2.91% |
| GROUP ONE TRADING, L.P. | 1,248,600 | $23,811,000 | 0.28% |
| SIMPLEX TRADING, LLC | 3,670 | $806,000 | 0.05% |
| Hudson Bay Capital Management LP | 22,500 | $429,000 | 0.01% |
| Citadel Advisors | 204,000 | $3,890,000 | 0.00% |